1. Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck
- Author
-
Julia Schnoell, Ulana Kotowski, Bernhard J. Jank, Stefan Stoiber, Elisabeth Gurnhofer, Michaela Schlederer, Gregor Heiduschka, Lukas Kenner, and Lorenz Kadletz-Wanke
- Subjects
THRB ,Medicine ,Medicine (miscellaneous) ,adenoid cystic carcinoma ,prognosis ,NIS ,CRYM ,health care economics and organizations ,Article - Abstract
The proteins sodium iodide symporter (NIS), μ-crystallin (CRYM), and thyroid hormone receptor beta (THRB) have been associated with prognosis in various cancer entities. While NIS and THRB may serve as possible therapeutic targets, the role of CRYM in cancer is still unclear. Protein levels of 44 patients with adenoid cystic carcinoma of the head and neck were analyzed using immunohistochemistry and correlated with clinicopathological data and outcome. NIS was positive in 72%, CRYM was positive in 55%, and THRB was positive in 39% of the patients. CRYM-positive adenoid cystic carcinomas were associated with a better cause-specific survival. Thus, our data indicate that CRYM might be a suitable positive prognostic marker in adenoid cystic carcinoma of the head and neck. Furthermore, expression of NIS was present in most patients and therefore evaluation of the use of radioiodine treatment is recommended.
- Published
- 2021